LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.


Ekizoglu S. , Dalay N., Karaman E. , Akdeniz D., Ozaydin A. , Buyru N.

Translational research : the journal of laboratory and clinical medicine, cilt.162, ss.122-9, 2013 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 162
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.trsl.2013.06.001
  • Dergi Adı: Translational research : the journal of laboratory and clinical medicine
  • Sayfa Sayıları: ss.122-9

Özet

The serine/threonine kinase liver kinase B 1 (LKB1) is a multifunctional protein and has been associated with various cancer types. Although the tumor suppressor function of LKB1 is attributed mainly to its ability to phosphorylate directly different adenosine monophosphate-activated protein kinases, its regulation is still poorly understood. More recently, it has been shown that LKB1 expression can be regulated by forkhead box O transcription factors via cis-acting elements, which are found in the promoter region of the LKB1 gene. In this study, we investigated LKB1 messenger RNA expression levels in association with the promoter methylation of the gene and forkhead box O member 3 (FOXO3) messenger RNA expression in head and neck squamous cell carcinoma (HNSCC) tumor samples. Our results show that LKB1 expression is downregulated, especially in advanced-stage tumor samples, and this downregulation was not the result of promoter methylation or modulation by FOXO3 (P = 0.656). Despite observing a positive association between the LKB1 and FOXO3 expression levels in the tumors, this association was not statistically significant (P = 0.24). Our results indicate that downregulation of LKB1 is independent of FOXO3 and may be implicated in the progression of HNSCC. (Translational Research 2013;162:122-129)